ASH 2018: A Guide to the Latest for Blood-Born... - CLL Support

CLL Support

22,532 members38,709 posts

ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More

wmay13241 profile image
8 Replies

The American Society of Hematology (ASH) annual meeting is being held December 1-4, 2018 in San Diego, CA. There is a guide at: xconomy.com/national/2018/1...

Written by
wmay13241 profile image
wmay13241
To view profiles and participate in discussions please or .
Read more about...
8 Replies
BettinaB profile image
BettinaB

Thank you, very helpful!

Lola69 profile image
Lola69

Imbruvica saved my life!

Justasheet1 profile image
Justasheet1

Thanks.

Jm954 profile image
Jm954Administrator

I would love to go .......

Newdawn profile image
NewdawnAdministrator in reply to Jm954

Me too! 😊

Newdawn

Jm954 profile image
Jm954Administrator in reply to Newdawn

We could go together one year :)

Newdawn profile image
NewdawnAdministrator in reply to Jm954

😀 Sounds good to me!

Newdawn

HannahHugo profile image
HannahHugo

My wife’s haematologist from Melbourne, Australia attending this to hear more about ibrutinib plus rituximab combination. Wife starting on ibrutinib after he gets back for she didn’t respond positively to 2 cycles of FCR.

First diagnosed with NHL (SLL) in 2008, treated with CHOP+R then returned as CLL in 2013, treated with CVP+R, now returned 2018. Also been receiving IgG infusions regularly.

Let’s hope the ASH conference reports plenty of encouraging options.

You may also like...

ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance

with Dr. Kipps at ASH 2018, he discusses resistance and how to possibly avoid it:...

ASH 2018: ECOG trial shows superiority of Ibrutinib and rituximab over FCR

patients <70 years old.. For more see:...

Late breaking CLL abstract at ASH 2018 (FCR vs IR for untreated younger patients)

https://ash.confex.com/ash/2018/webprogram/Paper120779.html CONCLUSIONS: The combination of...

ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of venetoclax for CLL

Today we posted on ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of...

Very Quick Day 1 Wrap from ASH 2018

None of the research has been presented at ASH 2018 in San Diego, but there is already a buzz about...